Authors
Loading...
Experimental study demonstrates rapamycin inhibits motility in mammalian cells by suppressing RhoA via mTORC1, indicating a key signaling axis for cytoskeleton reorganization.
Liu et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: